European Patent Office

T 0867/24 (Nasal composition / CHURCH & DWIGHT) vom 06.05.2026

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2026:T086724.20260506
Datum der Entscheidung
6. Mai 2026
Aktenzeichen
T 0867/24
Online am
2. Juni 2026
Antrag auf Überprüfung von
-
Anmeldenummer
14181205.7
Verfahrenssprache
Englisch
Verteilung
Nicht verteilt (D)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
NASAL COMPOSITION COMPRISING MIXTURE OF HYALURONIC ACIDS AND SALINE SOLUTION
Name des Antragstellers
Church & Dwight Co., Inc.
Name des Einsprechenden
Patentanwalt Dipl.-Ing. Dietze, Ingo
Kammer
3.3.07
Leitsatz
-
Relevante Rechtsnormen
Rules of procedure of the Boards of Appeal 2020 Art 012(3)Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(5)European Patent Convention Art 100(a)European Patent Convention Art 56
Schlagwörter
Reply to statement of grounds of appeal - reasons set out clearly and concisely (no)
Amendment to case - admitted (no)
Inventive step - (no)
Orientierungssatz
The requirements for clarity and conciseness of Article 12(3) RPBA preclude the presentation of arguments that are either confusing or unnecessarily protracted, to the extent that potentially relevant objections or requests risk being obscured within an overabundance of extraneous or repetitive content. Clarity and conciseness in submissions are essential to ensure that all parties can effectively engage with the core issues and that the proceedings remain efficient and equitable (see points 1.1-1.3 of the reasons).
Zitierte Akten
T 0321/21
Zitierende Akten
-

Order

For these reasons it is decided that:

The appeal is dismissed.